autolumo a1860 and a1800 immunoassay
The AutoLumo A1860/A1800

© Autobio Diagnostics

Sponsored • AutoLumo A1860/A1800

Immunoassay user experience: simple and smart

AutoLumo A1860/A1800 is the new generation of Autobio AutoLumo Series with compact structure and innovative design, providing simpler, smarter and better user experience for small and medium size labs.

According to the manufacturer, the device is characterized in particular by its simple operation and by enormous time savings and is intended to lead laboratories into a new generation of immunoassays. 

Highlighted is the low carryover: the vacuum around the wash station ensures low carryover, which is particularly advantageous for infectious diseases. An integrated RIDE module that combines reading, injection, discarding and elution achieves a low error rate. It is also characterized by the iconic management of consumables and the automatic switching of dual substrate. 

The bi-directional floating magnetic separation reduces nonspecific absorption. 25 reagent positions meet various clinical demand. With a throughput of 180 tests/hour, the instrument is a gamechanger in the stressful daily laboratory routine.

Autobio is a leading provider of comprehensive solutions for medical laboratories. The company specializes in R&D, production, marketing and service of clinical diagnostic products. 

Focusing on immunoassay, molecular, microbiology and POCT fields, Autobio helps healthcare professionals tailor treatment with fast, reliable and accurate diagnosis solution for various diseases and dysfunctions. Currently, Autobio has 529 product registration certificates, 322 CE marked and 528 patents.

Autobio is at Medica >> Hall 1 / F17

Source: Autobio Diagnostics Co.


Read all latest stories

Related articles


News • Presented at ESCMID Global

Immunoassay analyzer extends menu with new hepatitis assays

Beckman Coulter Diagnostics announced ahead of the ESCMID Global congress (formerly ECCMID) that it has extended the menu of DxI 9000 Immunoassay Analyzer* assays.


Article • QC at AACC 2023

New risk-based quality control assessment for clinical labs

Juggling the cost of quality control (QC) resources versus the risk of testing error is a balancing act no clinical laboratory manager enjoys. It is an inexact process, itself prone to error, which…


News • Drug discovery

New FDSS-GX: Hamamatsu presents high-performance kinetic plate imager

Hamamatsu Photonics announces the release of a new high-speed kinetic plate imager, the FDSS-GX, designed for kinetic cell-based assay development.

Related products

Subscribe to Newsletter